Capital Rx, a pharmacy benefit manager in the United States, announced yesterday that it has named Josh Golden as its new senior vice president of Strategy.
Golden has more than a decade of experience as a strategic consultant in the healthcare industry. He will evaluate market trends, assess business initiatives, and develop strategic partnerships to support Capital Rx's continued growth.
Earlier, Golden served as area senior vice president at Solid Benefit Guidance. Prior to joining Solid Benefit Guidance in 2016, he was the practice leader for the Employer Consulting Segment of Pharmaceutical Strategies Group LLC. He has also held strategic consulting positions at Aon Hewitt, Mercer Human Resource Consulting, and Buck Consultants.
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees
GXO appointed to manage NHS England bowel cancer home testing kits